GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Change In Payables And Accrued Expense

Artrya (ASX:AYA) Change In Payables And Accrued Expense : A$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Change In Payables And Accrued Expense?

Artrya's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was A$0.00 Mil. It means Artrya's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Dec. 2024 .

Artrya's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2024 was A$0.00 Mil. It means Artrya's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Jun. 2024 .

Artrya Change In Payables And Accrued Expense Historical Data

The historical data trend for Artrya's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Change In Payables And Accrued Expense Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Change In Payables And Accrued Expense
- - - -

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

Artrya Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artrya Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Artrya's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Artrya Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
ASX:PCK ASX:M7T ASX:BMT ASX:SHG ASX:ALC ASX:VHL ASX:MDR ASX:PHX ASX:BB1 ASX:RHT VEEV GEHC ASX:PME TEM DOCS TSE:2413 HQY WAY BTSG HKSE:02587
Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Website
https://www.artrya.com
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines